http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200840590-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cfc6d6c5d5c70bd8850f52efbb0607f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate | 2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444dab1c19449a3ae125c68554bb2b4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd3a8e377cd7713e9a3d4903f7913c3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c33ce4c8052f39985d2db6dfdd25939 |
| publicationDate | 2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200840590-A |
| titleOfInvention | Compositions and methods for prevention and treatment of cachexia |
| abstract | Compositions and methods for preventing and treating wasting disorders, such as cachexia and anorexia, are provided. In one aspect, the present invention provides a method for preventing and treating a wasting disorder in a mammal. In one embodiment, the method of the invention comprises administering to such mammal a macrolide and a β 2-adrenergic agonist in combination such that the macrolide and said β 2-agonist are administered in amounts effective to prevent or at least alleviate said wasting disorder. |
| priorityDate | 2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 318.